- Filed
- May 27, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 21, 2025 | 99M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 99M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 99M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$32.28K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$29.01K |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $176.09K |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $173.99K |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −$81.62K |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$47.24K |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | $53.2K |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | $84.26K |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $273.53K |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $271.43K |
| Total Assets | Q1 2025 · Mar 31, 2025 | $191.92K |
| Total Assets | Q1 2025 · Dec 31, 2024 | $224.19K |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | $0.00 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.00 |
| Net Income | Q1 2025 · Mar 31, 2025 | −$34.38K |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$31.06K |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$32.28K |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$28.96K |
| Gross Profit | Q1 2025 · Mar 31, 2025 | $0 |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $0 |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | $0 |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $0 |